Immunostimulatory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effect.
Antilymphocyte globulin (ALG) and antithymocyte globulin (ATG) have an established role in the treatment of severe aplastic anaemia. The response rate ranges from 40% to 80%. Its mode of action is believed to be complement dependent lysis of immunocompetent cells which inhibit haemopoietic maturation. This might not be the sole mechanism. We have tested four different preparations of ALG/ATG for their mitogenic effect on normal peripheral blood cells and on enriched T-cells in vitro by 3H-thymidine incorporation. We found marked differences between the four preparations. One was strongly mitogenic and able to induce profound release of haemopoietic growth factors. This mitogenic effect could be detected in the serum of patients during ALG treatment. Clinical response rates of this preparation are about 80%. Three other preparations were of lower or no stimulatory effect. Clinical response rates with these preparations vary between 40% and 60%. From our results, we postulate that the beneficial effect of ALG could be partially due to its ability to stimulate release of haemopoietic growth factors. The mitogenicity of different ALG/ATG preparations should be tested as an in vitro parameter of clinical efficacy.
Kawano
Y
Y
Department of Research, Kantonsspital Basel, Switzerland.
Nissen
C
C
Gratwohl
A
A
Speck
B
B
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D002455:Cell Division; D003114:Colony-Forming Units Assay; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008938:Mitosis; D013601:T-Lymphocytes / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000961:Antilymphocyte Serum